Study wrapper · #617
Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart.
Editor's note
Using isolated mouse hearts subjected to ischemia-reperfusion and single-cell patch clamp, researchers reported that the growth hormone secretagogues ghrelin and hexarelin preserved cardiomyocyte electrical properties. GHS treatment, given before or after ischemia, blunted injury-related declines in action-potential amplitude and duration and normalized several ion currents (L-type calcium, transient outward potassium, and sodium). The peptides also shifted stress-related signaling away from apoptosis (less p38 and JNK, more ERK1/2) via the GHS receptor 1a. This adds electrophysiological detail to hexarelin's cardioprotective story but is an ex-vivo, mechanistic model. These are preclinical findings; human data are needed before any clinical conclusions can be drawn.
Plain-language abstract
Ischemic heart disease can cause dangerous irregular heart rhythms. Researchers studied isolated mouse hearts that underwent a period of no blood flow followed by restored flow, then examined individual heart-muscle cells. They tested ghrelin (a natural hormone) and hexarelin (a synthetic version). Both peptides, whether given before or after the no-flow period, protected the cells' electrical activity, keeping the electrical signals and several ion 'currents' closer to normal. The peptides also nudged internal stress signals away from cell death and toward cell survival, acting through a specific receptor. The authors conclude these peptides help preserve heart-cell electrical function after injury. This is a preclinical study in isolated hearts and cells; human research would be needed before any clinical conclusions.